14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for 6160.HK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 100.65 2.97 %
R2 99.52 1.81 %
R1 98.83 1.10 %
Current price: 97.75
Support S1 96.57 -1.20 %
S2 95.88 -1.92 %
S3 94.75 -3.07 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 106.50 8.95 %
R2 106.00 8.44 %
R1 104.00 6.39 %
Current price 97.75
Support S1 97.05 -0.716%
S2 89.75 -8.18%
S3 88.85 -9.10%

6160.HK Predictions History

StockInvest.us BE THE FIRST TO PREDICT

The excellent way of becoming a better trader


  • Easy to use
  • Enhance your skills
  • Predict as many as you like
  • Request predictions
  • Gather points
  • Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

Click to get the best stock tips daily for free!

About BeiGene, Ltd.

BeiGene Ltd. BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; XGEVA to treat giant cell tu... 6160.HK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT